These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 9498205

  • 1. [111-indium DTPA octreotide scintigraphy in colorectal liver metastases].
    Seifert JK, Görges R, Bockisch A, Junginger T.
    Langenbecks Arch Chir; 1997; 382(6):332-6. PubMed ID: 9498205
    [Abstract] [Full Text] [Related]

  • 2. 111In-labelled somatostatin analogues in a rat tumour model: somatostatin receptor status and effects of peptide receptor radionuclide therapy.
    Capello A, Krenning E, Bernard B, Reubi JC, Breeman W, de Jong M.
    Eur J Nucl Med Mol Imaging; 2005 Nov; 32(11):1288-95. PubMed ID: 16021448
    [Abstract] [Full Text] [Related]

  • 3. A new radiolabelled somatostatin analogue [111In-DTPA-D-Phe1]RC-160: preparation, biological activity, receptor scintigraphy in rats and comparison with [111In-DTPA-D-Phe1]octreotide.
    Breeman WA, Hofland LJ, van der Pluijm M, van Koetsveld PM, de Jong M, Setyono-Han B, Bakker WH, Kwekkeboom DJ, Visser TJ, Lamberts SW.
    Eur J Nucl Med; 1994 Apr; 21(4):328-35. PubMed ID: 7911760
    [Abstract] [Full Text] [Related]

  • 4. [The scintigraphy of somatostatin receptors in the carcinoid tumor].
    Banzo J, Abós MD, Prats E, Delgado M, Razola P, García S, Gomollón F, García F.
    Rev Esp Med Nucl; 2001 Feb; 20(1):11-8. PubMed ID: 11181324
    [Abstract] [Full Text] [Related]

  • 5. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
    Eising EG, Farahati J, Bier D, Knust EJ, Reiners C.
    Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
    [Abstract] [Full Text] [Related]

  • 6. Somatostatin receptor scintigraphy of carcinoid tumours using the [111In-DTPA-D-Phe1]-octreotide.
    Westlin JE, Janson ET, Arnberg H, Ahlström H, Oberg K, Nilsson S.
    Acta Oncol; 1993 Feb; 32(7-8):783-6. PubMed ID: 8305227
    [Abstract] [Full Text] [Related]

  • 7. Distinguishing small hepatic hemangiomas from vascular liver metastases in gastrinoma: use of a somatostatin-receptor scintigraphic agent.
    Termanini B, Gibril F, Doppman JL, Reynolds JC, Stewart CA, Sutliff VE, Venzon DJ, Jensen RT.
    Radiology; 1997 Jan; 202(1):151-8. PubMed ID: 8988205
    [Abstract] [Full Text] [Related]

  • 8. Somatostatin receptor imaging in intracranial tumours.
    Schmidt M, Scheidhauer K, Luyken C, Voth E, Hildebrandt G, Klug N, Schicha H.
    Eur J Nucl Med; 1998 Jul; 25(7):675-86. PubMed ID: 9662588
    [Abstract] [Full Text] [Related]

  • 9. Indium-111-labelled octreotide scintigraphy in the diagnosis and management of non-iodine avid metastatic carcinoma of the thyroid.
    Christian JA, Cook GJ, Harmer C.
    Br J Cancer; 2003 Jul 21; 89(2):258-61. PubMed ID: 12865913
    [Abstract] [Full Text] [Related]

  • 10. Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study.
    Gibril F, Reynolds JC, Doppman JL, Chen CC, Venzon DJ, Termanini B, Weber HC, Stewart CA, Jensen RT.
    Ann Intern Med; 1996 Jul 01; 125(1):26-34. PubMed ID: 8644985
    [Abstract] [Full Text] [Related]

  • 11. Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide.
    Wangberg B, Forssell-Aronsson E, Tisell LE, Nilsson O, Fjalling M, Ahlman H.
    Br J Cancer; 1996 Mar 01; 73(6):770-5. PubMed ID: 8611378
    [Abstract] [Full Text] [Related]

  • 12. Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors.
    Frilling A, Malago M, Martin H, Broelsch CE.
    Surgery; 1998 Dec 01; 124(6):1000-4. PubMed ID: 9854575
    [Abstract] [Full Text] [Related]

  • 13. Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
    Baudin E, Lumbroso J, Schlumberger M, Leclere J, Giammarile F, Gardet P, Roche A, Travagli JP, Parmentier C.
    J Nucl Med; 1996 Jun 01; 37(6):912-6. PubMed ID: 8683310
    [Abstract] [Full Text] [Related]

  • 14. Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients.
    Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, van Hagen M, Postema PT, de Jong M, Reubi JC.
    Eur J Nucl Med; 1993 Aug 01; 20(8):716-31. PubMed ID: 8404961
    [Abstract] [Full Text] [Related]

  • 15. Somatostatin receptor scintigraphy in forty-eight patients with the Zollinger-Ellison syndrome. GRESZE: Groupe d'Etude du Syndrome de Zollinger-Ellison.
    de Kerviler E, Cadiot G, Lebtahi R, Faraggi M, Le Guludec D, Mignon M.
    Eur J Nucl Med; 1994 Nov 01; 21(11):1191-7. PubMed ID: 7859770
    [Abstract] [Full Text] [Related]

  • 16. Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide.
    Schillaci O, Annibale B, Scopinaro F, delle Fave G, Colella AC.
    J Nucl Med; 1997 Jun 01; 38(6):886-7. PubMed ID: 9189135
    [Abstract] [Full Text] [Related]

  • 17. Somatostatin receptor scintigraphy in central nervous system tumors: role of blood-brain barrier permeability.
    Haldemann AR, Rösler H, Barth A, Waser B, Geiger L, Godoy N, Markwalder RV, Seiler RW, Sulzer M, Reubi JC.
    J Nucl Med; 1995 Mar 01; 36(3):403-10. PubMed ID: 7884502
    [Abstract] [Full Text] [Related]

  • 18. 111In-DTPA-D-Phe-1-octreotide scintigraphy of small cell lung cancer.
    Bombardieri E, Chiti A, Crippa F, Seregni E, Cataldo I, Maffioli L, Soresi E.
    Q J Nucl Med; 1995 Dec 01; 39(4 Suppl 1):104-7. PubMed ID: 9002763
    [Abstract] [Full Text] [Related]

  • 19. High sensitivity of the in vivo detection of somatostatin receptors by 111indium (DTPA-octreotide)-scintigraphy in meningioma patients.
    Hildebrandt G, Scheidhauer K, Luyken C, Schicha H, Klug N, Dahms P, Krisch B.
    Acta Neurochir (Wien); 1994 Dec 01; 126(2-4):63-71. PubMed ID: 8042557
    [Abstract] [Full Text] [Related]

  • 20. The value of octreotide scintigraphy in patients with lung cancer.
    Kwekkeboom DJ, Kho GS, Lamberts SW, Reubi JC, Laissue JA, Krenning EP.
    Eur J Nucl Med; 1994 Oct 01; 21(10):1106-13. PubMed ID: 7828621
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.